UCI closes salbutamol case against Chris Froome

Chris Froome (Team Sky) lost more time on stage 9 of the 2018 to Gran Sasso d'Italia

The UCI has announced that it has closed its anti-doping proceedings against Chris Froome just five days before the start of this year's Tour de France. The Team Sky rider returned an anti-doping sample with twice the permitted level of salbutamol at the 2017 Vuelta a Espana, but the UCI has said that the results do not constitute an adverse analytical finding (AAF). “In light of WADA’s unparalleled access to information and authorship of the salbutamol regime, the UCI has decided, based on WADA’s position, to close the proceedings against Mr Froome,” read the UCI statement on Monday morning. “Whilst the UCI would have obviously preferred the proceedings to have been finalised earlier in the season, it had to ensure that Mr Froome had a fair process, as it would have done with any other rider, and that the correct decision was issued. Having received WADA’s position on 28 June ...

Read on Cycling News


More Like This

No similar articles :(